Ocular side effects of levitra ® (vardenafil) - results of a double-blind crossover study in healthy male subjects - Roessler, Gernot; Vobig, Michael; Walter, Peter; Mazinani, Babac AE (Drug design, development and therapy, 2019)
Keywords: Acuity; Administration, Oral; Adolescent; Adult; BASIC (programming language); Clinical Trial Report; Color; Color vision; Color Vision - drug effects; Comparative analysis; Cross-Over Studies; Diabetic retinopathy; Double-Blind Method; Double-blind studies; Drug dosages; Electrocardiography; Electroretinography; Erectile dysfunction; Errors; Germany; Humans; Latency; Male; Middle Aged; ocular side effects; Ophthalmology; Patient compliance; PDE-5-inhibitors; Phosphodiesterase 5 Inhibitors - administration & dosage; Phosphodiesterase 5 Inhibitors - adverse effects; Retina; Retina - drug effects; Retina - physiopathology; retinal function; Side effects; Tablets; Time Factors; Vardenafil Dihydrochloride - administration & dosage; Vardenafil Dihydrochloride - adverse effects; Visual acuity; Visual field; Visual fields; Young Adult; Germany; electroretinogram; phosophodiesterase-5 inhibitor; placebo-controlled; adverse events; color vision; retinal function